$BSPK
Bespoke Extracts, Inc. Stock $bspk

$bspk Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024058011 Filed on July 02, 2024

Income Statement

Concept	2024 Q3	2024 Q1
Revenue	$277.5K	$260.4K
YoY Change	13.53%	192.56%
Cost Of Revenue	$162.5K	$157.8K
YoY Change	11.28%	100.65%
Gross Profit	$115.0K	$102.6K
YoY Change	16.86%	891.22%
Gross Profit Margin	41.44%	39.39%
Selling, General & Admin	$290.7K	$347.9K
YoY Change	-16.39%	-7.12%
% of Gross Profit	252.81%	339.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.618K	$3.450K
YoY Change	-63.54%	93.28%
% of Gross Profit	2.28%	3.36%
Operating Expenses	$377.5K	$405.4K
YoY Change	-4.34%	-10.65%
Operating Profit	-$262.5K	-$302.8K
YoY Change	-11.39%	-31.7%
Interest Expense	-$13.15K	-$11.32K
YoY Change	-346.39%
% of Operating Profit
Other Income/Expense, Net	-$13.15K	$3.102K
YoY Change	146.3%	12.8%
Pretax Income	-$275.6K	-$314.1K
YoY Change	-8.59%	-28.71%
Income Tax
% Of Pretax Income
Net Earnings	-$275.6K	-$314.1K
YoY Change	-8.59%	-28.71%
Net Earnings / Revenue	-99.33%	-120.62%
Basic Earnings Per Share	-$0.03	-$0.03
Diluted Earnings Per Share	-$0.03	-$0.03
COMMON SHARES
Basic Shares Outstanding	10.17M shares	10.17M shares
Diluted Shares Outstanding	10.64M shares	10.17M shares

Balance Sheet

Concept	2024 Q3	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.45K	$14.42K
YoY Change
Cash & Equivalents	$21.45K	$14.42K
Short-Term Investments
Other Short-Term Assets	$12.30K	$7.350K
YoY Change	-51.69%	-90.81%
Inventory	$44.23K	$38.88K
Prepaid Expenses	$12.30K	$1.250K
Receivables	$46.08K	$43.13K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$124.1K	$103.8K
YoY Change	27.93%	-30.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.96K	$37.53K
YoY Change	-20.59%	-22.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.00K	$12.00K
YoY Change	0.0%	20.0%
Total Long-Term Assets	$214.0K	$252.1K
YoY Change	-26.51%	-23.55%
TOTAL ASSETS
Total Short-Term Assets	$124.1K	$103.8K
Total Long-Term Assets	$214.0K	$252.1K
Total Assets	$338.0K	$355.8K
YoY Change	-12.91%	-25.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.447M	$1.137M
YoY Change	74.74%	132.1%
Accrued Expenses	$73.52K	$64.33K
YoY Change	14.29%	7.22%
Deferred Revenue
YoY Change
Short-Term Debt	$86.87K	$58.37K
YoY Change	221.74%	-91.54%
Long-Term Debt Due	$120.4K	$85.31K
YoY Change
Total Short-Term Liabilities	$1.728M	$1.345M
YoY Change	86.73%	7.72%
LONG-TERM LIABILITIES
Long-Term Debt	$849.5K	$849.5K
YoY Change	0.0%
Other Long-Term Liabilities	$90.14K	$133.7K
YoY Change	-46.06%	-33.18%
Total Long-Term Liabilities	$939.6K	$983.2K
YoY Change	-7.57%	391.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.728M	$1.345M
Total Long-Term Liabilities	$939.6K	$983.2K
Total Liabilities	$2.667M	$2.328M
YoY Change	37.36%	60.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.22M	-$25.68M
YoY Change	4.46%	5.58%
Common Stock	$11.12K	$10.17K
YoY Change	9.39%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.329M	-$1.973M
YoY Change
Total Liabilities & Shareholders Equity	$338.0K	$355.8K
YoY Change	-12.91%	-25.64%

Cashflow Statement

Concept	2024 Q3	2024 Q1
OPERATING ACTIVITIES
Net Income	-$275.6K	-$314.1K
YoY Change	-8.59%	-28.71%
Depreciation, Depletion And Amortization	$2.618K	$3.450K
YoY Change	-63.54%	93.28%
Cash From Operating Activities	-$28.34K	-$97.19K
YoY Change	-720.13%	-53.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	25.00K	$105.0K
YoY Change	-377.78%	-43.85%
NET CHANGE
Cash From Operating Activities	-28.34K	-$97.19K
Cash From Investing Activities
Cash From Financing Activities	25.00K	$105.0K
Net Change In Cash	-3.340K	$7.809K
YoY Change	-24.6%	-138.91%
FREE CASH FLOW
Cash From Operating Activities	-$28.34K	-$97.19K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-52759
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	BESPOKE EXTRACTS, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4743354
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	12001 E. 33rd Avenue
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit O
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Aurora
CY2024Q1	dei	Entity Address Country EntityAddressCountry	CO
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80010
CY2024Q1	dei	City Area Code CityAreaCode	720
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	949-1143
CY2024Q1	dei	Security12b Title Security12bTitle	None
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10168552	shares
CY2024Q1	us-gaap	Cash Cash	14416	usd
CY2023Q4	us-gaap	Cash Cash	6607	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43125	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45226	usd
CY2024Q1	bspk	Prepaid Stock Awards PrepaidStockAwards	6104	usd
CY2023Q4	bspk	Prepaid Stock Awards PrepaidStockAwards	9206	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1250	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	38876	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	15800	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	103771	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	81839	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	37529	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	40979	usd
CY2024Q1	bspk	License License	10000	usd
CY2023Q4	bspk	License License	10000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	192536	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209542	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2024Q1	us-gaap	Assets Assets	355836	usd
CY2023Q4	us-gaap	Assets Assets	354360	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1137298	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	961255	usd
CY2024Q1	bspk	Notes Payable Secured Net Of Discount NotesPayableSecuredNetOfDiscount	14693	usd
CY2023Q4	bspk	Notes Payable Secured Net Of Discount NotesPayableSecuredNetOfDiscount	14693	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	85307	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1345306	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1078957	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	849500	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	849500	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	133652	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	150460	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2328458	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2078917	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10168220	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10168220	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9946067	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9946067	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	10166	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10166	usd
CY2024Q1	bspk	Common Stock Issued Shares CommonStockIssuedShares	6478	shares
CY2023Q4	bspk	Common Stock Issued Shares CommonStockIssuedShares	6478	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23697971	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23631918	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25680759	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25366641	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1972622	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1724557	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	355836	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	354360	usd
CY2024Q1	us-gaap	Revenues Revenues	260428	usd
CY2023Q1	us-gaap	Revenues Revenues	89016	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	157847	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	78667	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	102581	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	10349	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	347859	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	374515	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	57525	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	61204	usd
CY2023Q1	bspk	Consulting Fees ConsultingFees	18000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	405384	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	453719	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-302803	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-443370	usd
CY2024Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	11315	usd
CY2023Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	-2750	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11315	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2750	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-314118	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440620	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-314118	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-440620	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10168220	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10107108	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-672096	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	50000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92432	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-440620	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-970284	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1724557	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	15635	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50418	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-314118	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1972622	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-314118	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-440620	usd
CY2023Q1	bspk	Inventory Reserve InventoryReserve	40393	usd
CY2024Q1	us-gaap	Depreciation Depreciation	3450	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1785	usd
CY2024Q1	bspk	Amortization Of Right Of Use Asset Net AmortizationOfRightOfUseAssetNet	17006	usd
CY2023Q1	bspk	Amortization Of Right Of Use Asset Net AmortizationOfRightOfUseAssetNet	16348	usd
CY2024Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	3102	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	21544	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	942	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	50418	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92432	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2101	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	46483	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3750	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	19170	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23076	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	53403	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	176042	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	196256	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16808	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16150	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-97191	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-207068	usd
CY2023Q1	bspk	Payment Of Inventory Earnout PaymentOfInventoryEarnout	90000	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	277000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	5000	usd
CY2024Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	100000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	105000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	187000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	7809	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-20068	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6607	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24433	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14416	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4365	usd
CY2023Q1	bspk	Stock Issued To Wonderleaf For Fixed Assets And License StockIssuedToWonderleafForFixedAssetsAndLicense	50000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	15635	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	222223	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-97191	usd
CY2024Q1	bspk	Working Capital Deficit WorkingCapitalDeficit	1241535	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25680759	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for provision for credit losses and inventory valuation and reserves. Actual results could differ from those estimates. </p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	38876	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15800	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2024Q1	us-gaap	Taxes And Licenses TaxesAndLicenses	10000	usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	40000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49947	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49947	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12418	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9968	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37529	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40979	usd
CY2024Q1	us-gaap	Depreciation Depreciation	3450	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1785	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	849500	usd
CY2023Q3	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	5	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.05	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0464	pure
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	6000	usd
CY2024Q1	us-gaap	Purchase Obligation PurchaseObligation	600000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	192536	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	133652	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	197982	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M8D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	19098	usd
CY2024	us-gaap	Lease Cost LeaseCost	20148	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	59107	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	79380	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	72765	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	211252	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13270	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	197982	usd
CY2024Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	45-to-1
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	222223	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2022Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	266667	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	155556	shares
CY2023	us-gaap	Other Expenses OtherExpenses	70907	usd
CY2024Q1	us-gaap	Other Expenses OtherExpenses	3102	usd
CY2024Q1	bspk	Prepaid Stock Award PrepaidStockAward	6104	usd
CY2023	bspk	Prepaid Stock Award PrepaidStockAward	9206	usd
CY2024Q1	bspk	Share Issued And Sold To Investor ShareIssuedAndSoldToInvestor	100000	usd
CY2024Q1	bspk	Share Issued Percentage ShareIssuedPercentage	0.15	pure
CY2024Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	100000	shares
CY2024Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	900000	usd
CY2023Q3	bspk	Option To Purchase Share Of Common Stock OptionToPurchaseShareOfCommonStock	222500	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	44306	usd
CY2024Q1	bspk	Option To Purchase Share Of Common Stock OptionToPurchaseShareOfCommonStock	222500	shares
CY2024Q1	bspk	Share Based Compensation Arrangements By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.2
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P50Y
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P50Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	8030	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1065	usd
CY2024Q1	bspk	Option To Purchase Share Of Common Stock OptionToPurchaseShareOfCommonStock	99000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2024Q1	bspk	Future Expense FutureExpense	143723	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	487372	usd
CY2024Q1	us-gaap	Loans Payable LoansPayable	5000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	849500	usd
CY2023Q3	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	5	usd
CY2024Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	253938	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	156944	usd
CY2021Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	400000	usd
CY2022Q3	bspk	Operating Profit Percentage OperatingProfitPercentage	0.40	pure
CY2022Q4	us-gaap	Progress Payments Netted Against Inventory For Long Term Contracts Or Programs ProgressPaymentsNettedAgainstInventoryForLongTermContractsOrPrograms	90000	usd
CY2021Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	666667	shares
CY2021Q4	bspk	Premium Percentage PremiumPercentage	1.20	pure
CY2024Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	16000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10107108	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10168220	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q1	bspk	Inventory Reserve InventoryReserve		usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable		usd
CY2024Q1	us-gaap	Interest Paid InterestPaid		usd
CY2023Q1	us-gaap	Interest Paid InterestPaid		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	bspk	Stock Issued To Wonderleaf For Fixed Assets And License StockIssuedToWonderleafForFixedAssetsAndLicense		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001409197
CY2024Q1	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NONE

Files In Submission

Name	View Source	Status
0001213900-24-058011-index-headers.html	Edgar Link	pending
0001213900-24-058011-index.html	Edgar Link	pending
0001213900-24-058011.txt	Edgar Link	pending
0001213900-24-058011-xbrl.zip	Edgar Link	pending
bspk-20240331.xsd	Edgar Link	pending
ea0208424-10q_bespoke.htm	Edgar Link	pending
ea020842401ex31-1_bespoke.htm	Edgar Link	pending
ea020842401ex32-1_bespoke.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
bspk-20240331_lab.xml	Edgar Link	unprocessable
bspk-20240331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0208424-10q_bespoke_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bspk-20240331_cal.xml	Edgar Link	unprocessable
bspk-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BSPK
Bespoke Extracts, Inc. Stock $bspk

2024 Q3 Form 10-Q Financial Statement

#000121390024058011 Filed on July 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSPK Bespoke Extracts, Inc. Stock $bspk

2024 Q3 Form 10-Q Financial Statement

#000121390024058011 Filed on July 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSPK
Bespoke Extracts, Inc. Stock $bspk